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ABSTRACT 
Objective: Liver plays a pivotal role in regulating various physiological processes in the body such as metabolism, secretion, and storage. It has a 
great capacity to detoxify toxic substances and synthesize useful principles. The current study was designed to investigate the possible protective 
effects of Zingiber officinale (ginger) extract on liver fibrosis induced by carbon tetrachloride (CCl4
Methods: The animals were divided into four groups with eight rats in each. To induce liver fibrosis, Wistar albino rats received CCl
) in rats. 
4
Results: CCl
 (2 ml/kg 
diluted in corn oil) twice weekly for eight weeks. Rats were concurrently treated with Z. officinale extract at two different doses (300 and 600 
mg/kg/day).  
4 induced liver injury characterized by fibrotic changes, degenerated hepatocytes and focal accumulation of inflammatory cells. In 
addition, CCl4 
Conclusion: Z. officinale showed a marked hepatoprotective effect against CCl
administration produced a significant increase in serum aminotransferases, lipids, liver lipid peroxidation and nitric oxide. The 
hepatoprotective effects of Z. officinale extract were evidenced by the significant decrease in serum aminotransferases and liver lipid peroxidation. 
Further, concurrent treatment with either dose of Z. officinale enhanced liver glutathione and enzymatic antioxidant defenses.  
4
Keywords: Antioxidant, Ginger, Fibrosis, Oxidative stress 
–induced liver fibrosis and injury through the abolishment of 
oxidative stress and potentiation of the antioxidant defense system. 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
The liver plays a major role in food digestion and metabolism. It has 
a number of important functions including glycogen storage, 
decomposition of red blood cells and plasma protein synthesis. The 
liver clears the blood of waste products, drugs, and other poisonous 
substances, maintains the volume of blood and regulates the factors 
affecting clotting of blood. It is an irreplaceable organ and should not 
be neglected so as to avoid a number of major problems [1]. Liver 
regeneration remains a fascinating topic, still partly clouded to many 
as to the exact cellular and molecular mechanisms that bring about 
this phenomenon. Actually, liver regeneration is a fundamental 
mechanism by which the liver can withstand injury. Changes in the 
morphology and physiology of organs and tissues such as the liver 
might be due to the accumulation of reactive oxygen species (ROS) 
and reactive nitrogen species (RNS). Because hepatocytes are very 
rich in mitochondria and have a high respiratory rate, they are 
exposed to large amounts of ROS and permanent oxidative stress 
which may be involved in the hepatocyte dysfunction observed in 
the setting of fulminant hepatic failure [2]. 
In the absence of reliable liver protective drugs, attention is focused 
on natural antioxidants such as polyphenol compounds which are 
found in plants [3]. Global analysis of natural products is an 
important issue in developing new therapeutic managements for 
liver disease. Approximately 25% of the drugs prescribed 
worldwide at present come from plants and 60% of anti-infections 
drugs already on the market or under clinical investigations are of 
natural origin [4]. Zingiber officinale (ginger) is used traditionally to 
prevent or treat various liver diseases in many countries. The 
effectiveness of Z. officinale and other medicinal plants have inspired 
pharmaceutical scientists to search for new directions in drug 
discovery and development. Experimental studies had clearly 
demonstrated these compounds, which have proven antioxidant, 
antiviral or anti-carcinogenic properties, and have significant 
hepatoprotective activity with minimal systemic adverse effects [5]. 
Previous studies have demonstrated the ability of ginger root and its 
polyphenolic constituents, gingerols, and zerumbone, to scavenge 
superoxide anion and hydroxyl radicals [6, 7]. 
MATERIALS AND METHODS 
Chemicals 
CCl4
Preparation of Z. officinale extracts (GEx) 
 was purchased from Sigma-Aldrich Co. (St. Louis, USA). Diagnostic 
kits for liver enzymes [Aspartat aminotransferase (AST) and alanine 
aminotransferase (ALT)] were purchased from Randox Co. (Antrim, UK). 
All other chemicals were supplied by Sigma-Aldrich Co. (St. Louis, USA).  
Ginger dried roots were obtained from local market of Herbs and 
Medicinal plants. Authentication of the plant was carried out by staff 
members of Botany Department, Faculty of Science, Cairo University, 
Egypt. The powdered plant material was dissolved in corn oil as 
suspensions solution and used for treatment [8]. 
Animals and treatments 
Thirty-two healthy adult male albino Wistar rats (200±20 g),  
supplied by the animal house of National Research Centre, Giza 
(Egypt), and were used in the current investigation. The rats were 
maintained in controlled environment (25±1 °C) with air 
conditioning and a controlled temperature and humidity of 60%. 
Animals were provided access to standard laboratory chow and tap 
water ad libitum. Rats were kept under observation for one week 
before the onset of the experiment for acclimatization and to exclude 
any undercurrent infection. All experiments were carried out 
according to recommendations of the ethical conditions approved by 
the Ethics Committee of National Research Centre of Experimental 
Animals which confronted to the international ethics for handling 
and care of experimental animals. 
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Rats were randomly allocated into four groups having 8 rats in each 
as follows:  
Group I (Control): Rats received corn oil via oral gavage for 8 w. 
Group II (CCl4): Rats were administered CCl4 (2 ml/kg, twice/week; 
i. p.) for 8 w [9]. 
Group III (CCl4+G300): Rats were administered CCl4 (2 ml/kg, 
twice/week; i. p.) and GEx (300 mg/kg/day) via oral gavage for 8 w [10]. 
Group IV (CCl4+G600): Rats were administered CCl4
Data analysis was performed using Graph Pad Prism software (Graph 
Pad software, San Diego, California). For multiple comparisons, a one-
way analysis of variance (ANOVA) followed by the Tukey-Krammer test 
was carried out. The results are expressed as the mean±standard 
deviation (SD). Differences were considered significant at a p<0.05. 
 (2 ml/kg, 
twice/week; i. p.) and GEx (600 mg/kg/day) via oral gavage for 8 w [11]. 
The doses were adjusted consistently as indicated by any change in 
body weight to maintain comparable dosage over the study period. 
Sample preparation 
At the end of the experiment, animals were sacrificed under ether 
anesthesia, and blood samples were collected and allowed to coagulate 
at room temperature and then centrifuged at 12,000 rpm for 10 min to 
separate serum. The clear sera were collected and stored at-20 °C for 
biochemical assay of liver function biomarkers. The liver was rapidly 
excised and washed in chilled saline. Samples from the liver were stored 
in 10% formalin solution and processed for histological examination 
while other samples were homogenized (10% w/v) in physiological 
saline solution and centrifuged at 3000 rpm for 5 min. The supernatant 
was collected and stored at-20 °C until used. 
Biochemical assays 
Determination serum biomarkers  
Serum activity of the aminotransferases AST and ALT was determined 
spectrophotometrically according to the method of Reitman and Frankel 
[12] using commercial kits from Randox Laboratories (UK). Serum total 
cholesterol [13], triglycerides [14] and HDL-cholesterol [15] were 
assayed using commercial diagnostic kits (Randox, UK). Serum vLDL-
cholesterol concentration was calculated according to the following 
formula [16]: vLDL-cholesterol = triglycerides/5. Serum LDL-cholesterol 
level was calculated from the formula [17]: LDL-cholesterol = Total 
cholesterol–triglycerides/5–HDL-cholesterol. Nitrite, a stable end 
product of nitric oxide radical, was determined according to the method 
of Miranda et al. (2001) using Griess reagent [18]. 
Determination of oxidative stress and antioxidant system 
parameters 
Lipid peroxidation levels in liver homogenates were assayed by 
measurement of malondialdehyde (MDA) formation according to the 
method by Berton et al. [19]. Depend on McCord method [20], 
activities of the superoxide dismutase (SOD) was measured. 
Glutathione peroxidase (GPx) activity was measured according to 
the method of Wendel [21]. 
Histopathological study 
After the experimental period, animals were decapitated, pieces of liver 
from all group were immediately removed from each animal, fixed in 
10% neutral buffered formalin and transferred to Department of 
Histopathology, Faculty of Veterinary Medicine, KSU University (KSA) for 
preparation, sectioning and staining with haematoxylin and eosin (H&E) 
and with Masson’s Trichrome (MT) [22].  
Statistical analysis 
RESULTS 
As shown in fig. 1 CCl4-administered rats showed markedly (p<0.01) 
increased liver and liver/body weight ratio as compared to control rats. 
A significant reduction (p<0.01) in the liver/body weight ratio was noted 
in a high dose of GEx as compared to CCl4 
Data summarizing the effect of GEx on liver function markers in 
serum of experimental animals were represented in Tables 1. CCl
group, on the other hand, there 
was no significant change observed in low dose of GEx.  
4-
administered rats exhibited a significant increase in serum ALT and 
AST levels when compared with control rats. Treatment of CCl4-
induced rats with either dose of GEx markedly decreased serum ALT 
and AST as compared to CCl4–treated rats. There was a marked and 
highly significant (p<0.001) increase in the concentration of lipid 
profile (CHO, LDL & TG) in the CCl4-treated when compared with 
control group. However, Treatment of CCl4-induced rats with both 
doses of GEx markedly decreased serum ALT and AST when 
compared with CCl4–treated rats. On the other hand, there was 
significantly increase (p<0.001) in HDL levels in GEx treated rats as 
compared to CCl4
 
Fig. 1: Effects of GEx on liver to body weight ratio in CCl
-treated rats (table 1).  
 
4–
induced liver fibrosis in rats after 8 w of treatment. Data are 
expressed as mean±SD. **p<0.01 
 
In contrast, a significant increase in the level of MDA, an end product of 
lipid peroxidation, was observed in liver tissue of CCl4–treated group 
when compared with the control group (table 2). Treatment of the CCl4-
induced rats with either high or low dose of GEx markedly decreased 
(p<0.001) liver MDA as compared to CCl4
Data in table 2 showed that GSH, GPx, GRx, SOD and nitric oxide 
were measured as an index of hepatic antioxidant status. Significant 
decrease in hepatic GSH (p<0.05), GPx (p<0.001), GRx (p<0.001) and 
SOD (p<0.001) activity were observed in CCl
–treated rats.  
4-treated group as 
compared to the control group, while there was significantly 
increased (p<0.001) in NOx level. GEx treatment with high dose 
caused a significant elevation in tissue GSH (p<0.05), GPx (p<0.001), 
GRx (p<0.001) and SOD (p<0.001) activities as compared to CCl4 
group. On the other hand, data showed that there was a non-
significant change in tissue GSH content and GRx activity in low dose 
of GEx treated as compared to the CCl4
 
. Similarly, treatment with 
low or high dose of GRx caused a significant reduction (p<0.001) in 
tissue nitric oxide levels as compared to untreated rats. 
Table 1: Effect of ginger on serum lipid profile and aminotransferases in CCl4
Group parameter 
-induced liver fibrosis 
Control CCl CCl4 4+ CClG (300) 4+G (600) 
Total cholesterol (mg/dl) 181±3.7 384.6±13.9 176.7±13.76*** 110.9±8.5δδδ δδδaaa  
Triglycerides (mg/dl) 82.4±2.6 184.3±3.6 51.4±7.6*** 34.7±3.3δδδ 
HDL-cholesterol (mg/dl) 
δδδaaa 
51.4±1.9 30.8±1.2 63.4±2.2*** 52.4±3.1δδδ 
LDL-cholesterol (mg/dl) 
δδδaaa 
108.5±10 235.6±15.2 136.9±14.5*** 96.5±20.4δδδ 
AST (U/l) 
δδδaaa 
53.45±9.6 118±5.5 105.3±3.5*** 71.05±8.5δ 
ALT (U/l) 
δδδaaa 
36.9±2.6 257.7±27.3 214.4±9.3ᵟᵟ *** 153.8±16.9δδδaaa 
Data are expressed as the mean±SD. ***p<0.001 compared to control group, ᵟp<0.05, ᵟᵟp<0.01 & ᵟᵟᵟp<0.001 compared toCCl4 group and aaap<0.001 
compared to CCl4+G (300). 
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Table 2: Effect of ginger on hepatic antioxidant activities in CCl 4
Group parameters 
-induced liver fibrosis 
Control CCl CCl4 4+ CClG (300) 4+G (600) 
MDA (μmol/mg protein) 0.17±0.0 0.26±0.03 0.2±0.01*** 0.17±0.01δδ δδδ 
Nitric oxide (µmol/mg protein) 3.61±0.3 8.02±0.4 6.1±0.7*** 4.6±0.4δδδ 
GSH (µmole/mg protein)  
δδδaaa 
42.8±2.1 36.9±3.9 40.7±0.9 * 42.6±2.4
GPx (U/mg protein) 
δ 
751.8±34.6 365±24.8 505.3±53.5*** 622.7±30.6δδδ 
GRx (U/mg protein) 
δδδaaa 
237.4±1.9 199.7±7.1 205.7±6.2 *** 224.1±6.4
SOD (U/mg protein) 
δδδaaa 
94.6±3.8 63.6±2.7 72.2±2.2*** 85.5±4.7δδ δδδaaa 
Data are expressed as the mean±SD. ***p<0.001, *P<0.05 compared to control group, ᵟp<0.05, ᵟᵟp<0.01 & ᵟᵟᵟp<0.001 compared to CCl4 group and 
aaap<0.001 compared to CCl4+
 
G(300). 
Table 3: The ginger effects for area of positive staining with MT (%) 
Group Area % of positive staining 
(A) Control  1.14±0.35 
(B) CCl4 7.95±1.48  
(C) 
*** 
CCl4 4.51±1.1ᵟᵟ +G (300)  
(D) CCl4 3.37±0.75ᵟᵟᵟ 
 Data are expressed as the mean±SD. ***p<0.001 compared to 
control group and, ᵟᵟp<0.05 & ᵟᵟᵟp<0.001 compared to CClR4R group. 
 
 
Fig. 2: Light photomicrographs of liver tissue stained with H&E. 
Scale bar: 100 µm. 
 
 (A) showed normal hepatocytes and hepatic blood sinusoids, (B) 
showed liver of rat exposed to CClR4R in which focal areas of the liver 
have degenerated hepatocytes with fragmented nuclei and focal 
accumulation of inflammatory cells (arrow), (C) normally appeared 
hepatocytes and sinusoids from rat received ginger extract alone, 
and (D) liver of rat administered CClR4R and received ginger extract 
showed moderate improvement of hepatocellular degeneration and 
inflammatory cellular infiltration (arrow) 
 
 
Fig. 3: Liver of control and experimental groups.  
 
(A) Liver of control animal showing the normal hepatic architecture 
of classic lobules with a central vein (c) in the middle and portal 
tracts (p) at the periphery and the only little amount of connective 
tissue stroma (stained blue). (B) Hepatic toxicity induced by high 
dose of CClR4R showed marked hepatocyte damage in the form of 
degeneration, necrosis, inflammatory cellular infiltration and 
extensive fibrosis (f) which surrounded regenerative nodules (n) 
giving a histological picture very similar to cirrhosis. (C) These 
changes were markedly ameliorated (reversed) in the liver of rat 
suffering from hepatic toxicity and received ginger 300 mg/kg after 
exposure to CClR4R. (D) Even more amelioration (reversal) was 
observed in the liver of rat suffering from hepatic toxicity and 
received ginger 600 mg/kg. Scale bar = 200 µm 
Histopathological studies of the liver of CCl4 group showed several 
widened areas of inflammation surrounding degenerated and 
hepatic cell necrosis. Whereas, GEx treatment significantly alleviated 
the CClR4R–induced damage in rat liver (fig. 2 & 3). The 
histopathological alterations were summarized in table 3. 
DISCUSSION 
Plant-based whole foods provide thousands of primary and 
secondary metabolites to the human diet that are absorbed into the 
body due to their low molecular lipophilic nature. Herbal medicines 
derived from plant extracts are being increasingly utilized to treat a 
wide variety of clinical diseases [23]. Ginger has been cultivated for 
thousands of years as a spice and for medicinal purposes [24]. 
Kikusaki and Nakatani [25] reported that chemical constituents like 
gingerols and shogaols present in ginger exhibited strong 
antioxidant activity. Gingerol, the pungent factor in ginger, inhibited 
phospholipid peroxidation induced by the ferric chloride-ascorbate 
system [10]. Also, Sekiwa et al. [26] reported that novel glucosides 
related to gingerdiol from ginger have antioxidant activity. 
Therefore, the present study was designed to evaluate the potential 
hepatoprotective activity of ginger against liver injury and fibrosis 
induced by CClR4R in rats. 
Administration of CClR4R for 8 w induced liver injury and fibrosis as 
evidenced by the histopathological findings including collagen 
deposition, necrosis, degenerated hepatocytes with fragmented 
nuclei and focal accumulation of inflammatory cells. In addition, CClR4R 
supplementation produced a marked elevation in serum AST and 
ALT levels. The elevated activities of serum aminotransferases are 
indicative of cellular damage and loss of functional integrity of cell 
membranes in liver [27]. Concurrent oral supplementation with 300 
or 600 mg/kg ginger extract markedly alleviated histological liver 
architecture and decreased the release of aminotransferases from 
hepatocytes. These findings may be explained by the ability of ginger 
to condition the hepatocytes and preserve the cell membrane 
integrity as reported in the study of Motawi et al. [28].  
In the present investigation, the liver to body weight ratio was 
measured as an indicator of the development of liver fibrosis and 
serum lipids were measured as a second indicator for liver function 
disturbances. The liver to body weight ratio as well as serum lipids 
was extremely elevated in the CClR4R–induced rats, demonstrating 
liver injury and hypertrophy due to collagen deposition. Concurrent 
treatment with ginger potentially ameliorated liver to body weight 
ratio and serum lipid profile. More interestingly, ginger treatment 
significantly increased serum HDL-cholesterol levels. The lipid 
lowering effect of ginger has been previously reported, suggesting 
that it is able to inhibit lipid hydrolase in intestinal tract [29], 
Hasan et al. 
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increase pancreatic lipase and amylase [30], reduce lipid peroxidase 
[31], increase intestinal peristalsis [32] and increase cholesterol 
conversion to bile acids [33]. Thus, it seems that the lipid-lowering 
activity of ginger plays a key protective role against CCl
+G (600)  
4
Evidence developed over the last years has suggested that various 
forms of liver injuries may be caused by free radical formation and 
subsequent oxidative stress. It is believed that ROS may injure cell 
membranes through lipid peroxidation [34]. As a xenobiotic, CCl
. 
4 
causes oxidative stress and may injure hepatic cells [35]. Many 
studies have established the fact that CCl4 is metabolized in the liver 
into a highly reactive substance, trichloromethyl, which induces the 
formation of free radicals [36]. The produced free radicals bind 
covalently to macromolecules and induce peroxidative degradation 
of membrane lipids [37]. The present data revealed a marked 
increase in the lipid peroxidation marker, MDA, and nitric oxide levels 
in the liver of CCl4-intoxicated rats. Subsequently, liver GSH and 
activity of the antioxidant enzymes were markedly declined due to 
CCl4
Oral supplementation of the CCl
-induced oxidative stress. The imbalance between the formation 
and removal of free radicals in the body, due to the reduction of 
endogenous antioxidants or increased generation of oxidizing species, 
favors the occurrence of oxidative lesions in macromolecules and 
cellular structures, and possibly result in cell death [38]. 
4-induced rats with either dose of 
ginger significantly decreased liver lipid peroxidation and nitric 
oxide levels, and potentiated the enzymatic and non-enzymatic 
defenses. Accordingly, the study of Motawi et al. [28], a significant 
increase in lipid peroxidation after 6 w of CCl4 administration has 
been reported. The authors also demonstrated the ability of a 200 
mg/kg dose of different ginger extracts to counteract CCl4-induced 
oxidative stress; however, they didn’t study the effect of different 
doses. Here, we demonstrated the dose-dependent antioxidant and 
free radical scavenging activity of ginger in CCl4
The observed hepatoprotective and antioxidant effects of ginger are 
associated with its active ingredients. [6]-shogaol, [6]-
dehydroshogaol and 1-dehydro-[6]-gingerdione were reported to be 
potent inhibitors of nitric oxide synthesis in activated macrophages 
[41]. The antioxidant activity of [6]-gingerol against phospholipids 
peroxidation and linoleic acid autoxidation has been demonstrated 
by previous studies [42]. [6]-gingerol also protected against from 
lipopolysaccharide-induced oxidative damage of DNA in rats [43]. In 
addition, [6]-shogaol has exhibited the most potent antioxidant 
properties, compared to [8]-gingerol, [6]-gingerol and [10]-gingerol 
[44]. Moreover, previous studies showed that the volatile oil of 
ginger influences both the non-specific proliferation of T lymphocyte 
and cell-mediated immune response, thus exert beneficial effects in 
a number of clinical conditions [45]. 
-induced rats for 8 
w. We assumed that the hepatoprotective effect of ginger could be 
attributed, at least in part, to the prevention of GSH decline and 
potentiation of the antioxidant enzymes. In this context, the study of 
Ansari et al. [39] showed that pretreatment of isoproternol-induced 
with ethanolic Z. officinale extract for 20 d enhanced the antioxidant 
defenses and exhibited cardioprotective property. On the other 
hand, Jung et al. [40] reported the ability of ginger extract to inhibit 
the excessive production of nitric oxide. 
In conclusion, the present study provides evidence on the 
hepatoprotective and anti-fibrosis effects of ginger. Ginger restored 
the altered biochemical profile due to CCl4 exposure towards 
normalization. Through its potent antioxidant activity, ginger 
maintained the integrity of plasma membrane and increased the 
regenerative and reparative capacity of the liver. In addition, the 
current data conferred new information on the possible involvement 
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